Medlive Technology Co (HKSE:02192) Altman Z2-Score: 27.84 (As of Aug. 03, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02192 Medlive Technology Co Ltd HKSE:02192
90 GF Score
Price HK$7.87
GF Value HK$14.95
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Medlive Technology Co Altman Z2-Score?

Medlive Technology Co HKSE:02192 +0.90% 90 Altman Z2-Score is 27.84 as of Aug. 03, 2026, which is 8% above its 10-year median of 25.87. GuruFocus rates HKSE:02192 with a GF Score™ of 90/100 and a GF Value™ of HK$14.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Medlive Technology Co ranks better than 98.95% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Medlive Technology Co has a Altman Z2-Score of 27.84, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Medlive Technology Co's Altman Z2-Score or its related term are showing as below:

HKSE:02192' s Altman Z2-Score Range Over the Past 10 Years
Min: 5.08   Med: 25.87   Max: 35.31
Current: 27.84

During the past 8 years, Medlive Technology Co's highest Altman Z2-Score was 35.31. The lowest was 5.08. And the median was 25.87.


Medlive Technology Co  (HKSE:02192) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Medlive Technology Co Altman Z2-Score Related Terms


Medlive Technology Co Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Medlive Technology Co's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medlive Technology Co Altman Z2-Score Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial 35.31 33.31 25.83 25.91 27.84

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.83 0.00 25.91 0.00 27.84

HKSE:02192 vs VEEV, BTSG, HQY: Altman Z2-Score Comparison

For the Health Information Services subindustry, Medlive Technology Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Altman Z2-Score falls into.


HKSE:02192
90GF Score
Medlive Technology Co Ltd HKSE:02192
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medlive Technology Co Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Medlive Technology Co's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.7333+3.26*0.1057+6.72*0.07+1.05*21.1543
=27.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$5,697.1 Mil.
Total Current Assets was HK$4,408.9 Mil.
Total Current Liabilities was HK$231.0 Mil.
Retained Earnings was HK$601.9 Mil.
Pre-Tax Income was HK$398.0 Mil.
Interest Expense was HK$-0.6 Mil.
Total Liabilities was HK$254.0 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(4408.894 - 230.999)/5697.107
=0.7333

X2=Retained Earnings/Total Assets
=601.947/5697.107
=0.1057

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(398.019 - -0.61)/5697.107
=0.07

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(5372.897 - 0)/253.986
=21.1543

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Medlive Technology Co has a Altman Z2-Score of 27.84 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 27.84 mean?
Medlive Technology Co (HKSE:02192) has a Altman Z2-Score of 27.84 as of Aug. 03, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Medlive Technology Co and its competitors. This is near median its historical median of 25.87. Over the past decade, Medlive Technology Co's Altman Z2-Score has ranged from 5.08 to 35.31. According to the industry distribution chart, Medlive Technology Co ranks #7 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 1.1%.
Is Medlive Technology Co's Altman Z2-Score too high?
Medlive Technology Co's current Altman Z2-Score of 27.84 is near median its 10-year median of 25.87. Over the past 10 years, this metric has ranged from a low of 5.08 to a high of 35.31. The Healthcare Providers & Services industry median Altman Z2-Score is 2.19. Medlive Technology Co's value of 27.84 is 1171.2% above this industry median. Based on the distribution chart, Medlive Technology Co ranks #7 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medlive Technology Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medlive Technology Co's Altman Z2-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Medlive Technology Co ranks #7 out of 666 companies for Altman Z2-Score. This places Medlive Technology Co in the top 1% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 2.19. Medlive Technology Co's value of 27.84 is 1171.2% above this benchmark. Historically, Medlive Technology Co's own Altman Z2-Score has ranged from 5.08 to 35.31 over the past decade. While the company's 10-year median is 25.87 vs. the industry median of 2.19, Medlive Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.19, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medlive Technology Co's current Altman Z2-Score of 27.84 is 1171.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Medlive Technology Co and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medlive Technology Co's current Altman Z2-Score is 27.84, which is near median its own 10-year median of 25.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medlive Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Medlive Technology Co (HKSE:02192) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.95, compared to a current price of HK$7.87 — trading 47.4% below its estimated fair value. The current Altman Z2-Score is 27.84, which is near median its 10-year median of 25.87 and 1171.2% above the Healthcare Providers & Services industry median of 2.19. Medlive Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Medlive Technology Co (HKSE:02192), the current Altman Z2-Score is 27.84 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medlive Technology Co (HKSE:02192) Overvalued in 2026?

Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued. The current stock price of HK$7.87 is trading 47.4% below its estimated GF Value™ of HK$14.95. GuruFocus considers Medlive Technology Co to be Significantly Undervalued.

Key valuation signals for HKSE:02192:

  • Altman Z2-Score: 27.84 (near median its 10-year median of 25.87)
  • GF Value™: HK$14.95 vs. price of HK$7.87 (47.4% below fair value)
  • GF Score™: 90/100 with 5 warning signs
  • Industry Position: 1171.2% above the Healthcare Providers & Services median (#7 of 666)

No single metric tells the full story. See the HKSE:02192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medlive Technology Co Business Description

Address Huangqu East Road No. 5, Courtyard Building 4, Yimaitong Mansion, Chaoyang District, Beijing, CHN
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score

Get the complete analysis for HKSE:02192

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$7.87
Price
HK$14.95
GF Value